Ligand Pharmaceuticals
LGND
#2736
Rank
โ‚ฌ5.59 B
Marketcap
279,94ย โ‚ฌ
Share price
2.60%
Change (1 day)
54.41%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): 1,43ย โ‚ฌ

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 8,92ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,76ย โ‚ฌ a decrease over its 2021 EPS that were of 3,08ย โ‚ฌ.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)1,43ย โ‚ฌ-181.31%
2022-1,76ย โ‚ฌ-157.23%
20213,08ย โ‚ฌ-2571.43%
2020-0,12ย โ‚ฌ-100.46%
201927,28ย โ‚ฌ353.48%
20186,01ย โ‚ฌ1025%
20170,53ย โ‚ฌ-700%
2016-0,08911ย โ‚ฌ-100.87%
201510,30ย โ‚ฌ1859.32%
20140,53ย โ‚ฌ5.36%
20130,50ย โ‚ฌ8.0704505322479E+18%
20120,0000000000ย โ‚ฌ-100%
20110,44ย โ‚ฌ-194.23%
2010-0,46ย โ‚ฌ548.38%
2009-0,07147ย โ‚ฌ-98.7%
2008-5,51ย โ‚ฌ-136.52%
200715,08ย โ‚ฌ-787.8%
2006-2,19ย โ‚ฌ-14.58%
2005-2,57ย โ‚ฌ-21.31%
2004-3,26ย โ‚ฌ-55.15%
2003-7,27ย โ‚ฌ81.33%
2002-4,01ย โ‚ฌ2.74%
2001-3,90ย โ‚ฌ-45.93%
2000-7,22ย โ‚ฌ-9.65%
1999-7,99ย โ‚ฌ-45.52%
1998-14,66ย โ‚ฌ-3.97%
1997-15,27ย โ‚ฌ132.31%
1996-6,57ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
5,96ย โ‚ฌ-33.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
0,68ย โ‚ฌ-92.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
27,50ย โ‚ฌ 208.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
14,45ย โ‚ฌ 62.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-1,26ย โ‚ฌ-114.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,88ย โ‚ฌ-90.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,03ย โ‚ฌ-54.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,56ย โ‚ฌ-71.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-0,32ย โ‚ฌ-103.60%๐Ÿ‡บ๐Ÿ‡ธ USA